Georgios Poupouzas

Mr. Georgios Poupouzas

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2024 in Life
Verified
Journal Article
Open access
PDF file
CVCharikleia Vrettou
Charikleia Vrettou
VIVasileios Issaris
Vasileios Issaris
SKStelios Kokkoris
Stelios Kokkoris
GPGeorgios Poupouzas
Georgios Poupouzas
CKChrysi Keskinidou
Chrysi Keskinidou
AVAlice Vassiliou
Alice Vassiliou
Aquaporins (AQPs) are membrane proteins facilitating water and other small solutes to be transported across cell membranes. They are crucial in maintaining cellular homeostasis by regulating water permeability in various tissues. Moreover, they regulate cell migration, signaling pathways, inflammation, tumor growth, and metastasis. In critically ill patients, such as trauma, sepsis, and patients with acute respiratory distress syndrome (ARDS), which are frequently encountered in intensive care units (ICUs), water transport regulation is crucial for maintaining homeostasis, as dysregulation can lead to edema or dehydration, with the latter also implicating hemodynamic compromise. Indeed, AQPs are involved in fluid transport in various organs, including the lungs, kidneys, and brain, where their dysfunction can exacerbate conditions like ARDS, acute kidney injury (AKI), or cerebral edema. In this review, we discuss the implication of AQPs in the clinical entities frequently encountered in ICUs, such as systemic inflammation and sepsis, ARDS, AKI, and brain edema due to different types of primary brain injury from a clinical perspective. Current and possible future therapeutic implications are also considered.

6 December 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
CVCharikleia Vrettou
Charikleia Vrettou
VIVasileios Issaris
Vasileios Issaris
SKStelios Kokkoris
Stelios Kokkoris
GPGeorgios Poupouzas
Georgios Poupouzas
CKChrysi Keskinidou
Chrysi Keskinidou
AVAlice Vassiliou
Alice Vassiliou
Aquaporins (AQPs) are membrane proteins facilitating water and other small solutes to be transported across cell membranes. They are crucial in maintaining cellular homeostasis by regulating water permeability in various tissues. Moreover, they regulate cell migration, signaling pathways, inflammation, tumor growth, and metastasis. In critically ill patients, such as trauma, sepsis, and patients with acute respiratory distress syndrome (ARDS), which are frequently encountered in intensive care units (ICUs), water transport regulation is crucial for maintaining homeostasis, as dysregulation can lead to edema or dehydration, with the latter also implicating hemodynamic compromise. Indeed, AQPs are involved in fluid transport in various organs, including the lungs, kidneys, and brain, where their dysfunction can exacerbate conditions like ARDS, acute kidney injury (AKI), or cerebral edema. In this review, we discuss the implication of AQPs in the clinical entities frequently encountered in ICUs, such as systemic inflammation and sepsis, ARDS, acute kidney injury (AKI), and brain edema due to different types of primary brain injury from a clinical perspective. Current and possible future therapeutic implications are also considered.

18 June 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
PPPantelis Papanastasiou
Pantelis Papanastasiou
SCStavroula Chaloulakou
Stavroula Chaloulakou
DKDimitrios Karagiannis
Dimitrios Karagiannis
AAAvra Almperti
Avra Almperti
GPGeorgios Poupouzas
Georgios Poupouzas
IDIoanna Dimopoulou
Ioanna Dimopoulou
Background/Objectives: The phase angle (PhA) is an emerging biomarker reflecting the cellular integrity and nutritional status. This study aimed to explore potential associations between the PhA, clinical severity scores, and 60-day survival outcomes following an admission to the Intensive Care Unit (ICU). Methods: This prospective, single-center study included 43 critically ill patients admitted to the ICU at Evangelismos General Hospital between May and November 2024. Patients were stratified by their PhA (≤5.4° vs. >5.4°). The PhA was measured at admission and subsequently on days 5–7, 10–11, 13–14, and until discharge. Severity scores (SOFA and APACHE II) were recorded. Between-group differences were assessed using independent samples t-tests and Mann–Whitney U tests, as appropriate. Survival was analyzed using Kaplan–Meier curves and Cox proportional hazards models. Results: The mean age was 54.6 ± 17 years; 63.6% were male. At ICU admission, patients with a PhA > 5.4° were significantly younger (p < 0.001) and had a higher fat-free mass (p < 0.001), greater calf circumference (p < 0.001), higher extracellular water (p < 0.001), larger mid-upper arm circumference (p = 0.009), and higher resting energy expenditure per kilogram (27.4 vs. 23.1 kcal/kg, p = 0.002). The PhA declined significantly during the ICU stay (p < 0.001). The Kaplan–Meier analysis showed a significantly shorter survival in patients with a PhA ≤ 5.4° (HR: 6.32, p = 0.019), which remained significant after adjusting for sepsis (p = 0.017). In a multivariable Cox regression, both PhA and APACHE II scores independently predicted mortality. Conclusions: While limited by a small sample size and single-center design, these findings support the further exploration of the PhA as a monitoring tool in critical care.

26 February 2025 in Advances in Medical Sciences
Verified
Journal Article
Closed access
CVCharikleia Vrettou
Charikleia Vrettou
CKChrysi Keskinidou
Chrysi Keskinidou
AVAlice Vassiliou
Alice Vassiliou
GPGeorgios Poupouzas
Georgios Poupouzas
EJEdison Jahaj
Edison Jahaj
IDIoanna Dimopoulou
Ioanna Dimopoulou

23 October 2026 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
VPVasiliki Petta
Vasiliki Petta
GHGeorgios Hillas
Georgios Hillas
VIVasileios Issaris
Vasileios Issaris
GPGeorgios Poupouzas
Georgios Poupouzas
APAndriana I Papaioannou
Andriana I Papaioannou
paraskevi katsaounouparaskevi katsaounou
paraskevi katsaounou
Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death worldwide. Bronchodilators remain the cornerstone of treatment due to the markable therapeutic effect of these drugs. Long-Acting β2-Adrenoreceptor agonists (LABAs) and Long-Acting Muscarinic Acetylcholine receptor antagonists (LAMAs) relieve bronchospasm, reduce air trapping, improve dyspnea, and reduce exercise intolerance. Despite the gradual, remarkable improvement in inhalation devices and the extended duration of action of newer agents, the β2-adrenoreceptor class may exhibit a reduced bronchodilator effect over time. Moreover, COPD is a complex, chronic inflammatory airway disease, often associated with multiple comorbidities and safety concerns related to the long-term use of currently available bronchodilators, further underscoring the need for new therapeutic classes. Consequently, there is growing interest in developing novel agents to expand treatment options and improve outcomes in COPD.

22 July 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
DKDimitrios Karagiannis
Dimitrios Karagiannis
AYAnna Elena Yatsulava
Anna Elena Yatsulava
DKDimitra Katsigianni
Dimitra Katsigianni
GPGeorgios Poupouzas
Georgios Poupouzas
CVCharikleia Vrettou
Charikleia Vrettou
IDIoanna Dimopoulou
Ioanna Dimopoulou
Background/Objectives: Resting energy expenditure (REE) rises during critical illness, but its determinants and prognostic relevance remain incompletely characterized. Identifying a circulating signal that tracks REE could provide a bedside surrogate for metabolic demand where indirect calorimetry is unavailable. This prospective pilot study described longitudinal trajectories of indirect calorimetry-measured REE, Sequential Organ Failure Assessment (SOFA) score, serum cortisol and insulin-like growth factor-1 (IGF-1) over two weeks in the intensive care unit (ICU), examined whether the REE trajectory was attenuated by adjustment for these variables, and generated preliminary effect-size and variance estimates for mortality. Methods: This single-center pilot study enrolled 39 critically ill adults at Evangelismos General Hospital (Athens, Greece); sample size was pragmatic, not based on an a priori power calculation. REE (Q-NRG metabolic monitor), cortisol and IGF-1 were measured at admission and days 5–7, 10–11 and 13–14, alongside SOFA. Trajectories were modeled with linear mixed-effects models using all available repeated measures. Confounding was assessed by adding SOFA, cortisol and IGF-1 as covariates and evaluating attenuation of the time effect; no formal mediation analysis was performed. Causes of missing data were quantified and a completers-only sensitivity analysis was undertaken. Mortality was analyzed by Cox regression with ICU length of stay as the time variable. Estimation was emphasized throughout; point estimates and 95% confidence intervals (CIs) are reported in preference to significance testing. Results: Mean age was 54.6 ± 18.1 years; 69.2% were male; median admission SOFA was 6 (IQR 3–9). ICU and 28-day mortality were 20.5% (8/39) and 10.3% (4/39). REE/kg rose from 25.3 ± 3.7 to a peak of 27.2 ± 4.2 kcal/kg/day by days 10–11 (likelihood-ratio χ2 = 17.2, p = 0.0006). Attrition was driven predominantly by discharge alive (18 of 23 patients missing at days 13–14) rather than death (n = 2), and the trajectory was preserved in a completers-only sensitivity analysis (χ2 = 9.13, p = 0.028). Cortisol declined (21.1 to 13.4 μg/dL) and IGF-1 rose (80.0 to 105.4 ng/mL); SOFA was essentially unchanged. REE did not correlate with SOFA, cortisol or IGF-1 at any time-point, and the time effect was not attenuated by adjustment for them. Admission REE was not associated with ICU mortality (HR 1.00, 95% CI 1.00–1.00). Higher admission REE was associated with a longer ICU stay, and this persisted after adjustment for body mass index (p = 0.026) and fat-free mass (p = 0.001). Age (HR 1.04, 95% CI 1.00–1.09) and admission SOFA (HR 1.18, 95% CI 0.98–1.44) were the covariates most associated with ICU mortality. Conclusions: REE rose progressively over the first 10–11 days of critical illness. Its trajectory was not attenuated by adjustment for SOFA, cortisol or IGF-1, which is compatible with—but does not establish—independence from the adrenal and somatotropic markers measured here. Neither REE nor these hormones were associated with mortality; age and disease severity remained the dominant prognostic factors, supporting a larger confirmatory study.